Sort
48,018 grants matching “immunotherapy”
Dissecting the tumor-intrinsic and -extrinsic roles of TBK1 in tumor immunity
$569,782Russell William Jenkins · Medical University Of South Carolina · R37 · FY2025 · CA
Determining how a Werner helicase (WRN) tumor suppressor complex regulates the human papillomavirus 16 life cycle
$569,781Iain Morgan · Virginia Commonwealth University · R01 · FY2021 · DE
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
$569,704Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Balancing protective immunity and chronic sequelae by resident CD8 T cells
$569,694Jie Sun · University Of Virginia · R01 · FY2022 · AI
Balancing protective immunity and chronic sequelae by resident CD8 T cells
$569,694Jie Sun · University Of Virginia · R01 · FY2024 · AI
Balancing protective immunity and chronic sequelae by resident CD8 T cells
$569,694Jie Sun · University Of Virginia · R01 · FY2023 · AI
Regulation of anti-tumor immunity by HDAC11
$569,672Edward Seto · George Washington University · R01 · FY2022 · CA
Identification and assessment of unconventional tumor-associated antigens as potential targets for cytotoxic T-cell based immunotherapy of cancer
$569,619Gregory A Lizee · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Studies of Materials with Physiological Properties
$569,600Stuart L Schreiber · Broad Institute, Inc. · R35 · FY2022 · GM
Studies of Materials with Physiological Properties
$569,600Stuart L Schreiber · Broad Institute, Inc. · R35 · FY2020 · GM
Studies of Materials with Physiological Properties
$569,600Stuart L Schreiber · Broad Institute, Inc. · R35 · FY2018 · GM
Studies of Materials with Physiological Properties
$569,600Stuart L Schreiber · Broad Institute, Inc. · R35 · FY2021 · GM
Studies of Materials with Physiological Properties
$569,600Stuart L Schreiber · Broad Institute, Inc. · R35 · FY2019 · GM
Molecular Targeted Photoimmunotherapy for Bladder Cancer
$569,459Piyush Agarwal · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
T cell migration and cardiovascular toxicity in immunotherapy
$569,426Minsoo Kim · University Of Rochester · R01 · FY2019 · AI
T cell migration and cardiovascular toxicity in immunotherapy
$569,426Minsoo Kim · University Of Rochester · R01 · FY2023 · AI
T cell migration and cardiovascular toxicity in immunotherapy
$569,426Minsoo Kim · University Of Rochester · R01 · FY2022 · AI
T cell migration and cardiovascular toxicity in immunotherapy
$569,426Minsoo Kim · University Of Rochester · R01 · FY2020 · AI
T cell migration and cardiovascular toxicity in immunotherapy
$569,426Minsoo Kim · University Of Rochester · R01 · FY2021 · AI
ITIM-receptors for cancer treatment
$569,405Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2023 · CA
Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer
$569,381Vinod P Balachandran · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Bifunctional T cell receptor based immunotherapeutics
$569,336Altor Bioscience Corporation · R44 · FY2005 · CA
Research Program in Immunology
$569,312Boston University Medical Campus · T32 · FY2004 · AI
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
$569,307Susan M Kaech · Salk Institute For Biological Studies · R01 · FY2024 · CA
Targeting Effector Immune cells to Cancer with Chemically Self-Assembled Nanorings (CSANs)
$569,277Carston R. Wagner · University Of Minnesota · R01 · FY2021 · CA